BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26087086)

  • 1. Infantile hemangioma associated with PHACES syndrome showing a dramatic response to oral propranolol.
    Singh BA; Harsha YS; Reddy BS
    Indian J Dermatol Venereol Leprol; 2015; 81(5):549. PubMed ID: 26087086
    [No Abstract]   [Full Text] [Related]  

  • 2. Facial segmental haemangioma with PHACE Syndrome successfully treated with oral propranolol.
    Lim TH; Yap E; Norhatizah BS
    Med J Malaysia; 2019 Oct; 74(5):447-449. PubMed ID: 31649228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol and prednisolone combination for the treatment of segmental haemangioma in PHACES syndrome.
    Gnarra M; Solman L; Harper J; Batul Syed S
    Br J Dermatol; 2015 Jul; 173(1):242-6. PubMed ID: 25639889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemangioma and propranolol.
    Engberg Damsgaard T; Vandborg Bjerre J
    J Plast Surg Hand Surg; 2014 Feb; 48(1):86-8. PubMed ID: 23837510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saving PHACE.
    Tavella SK; Ng YT
    Pediatr Neurol; 2018 Aug; 85():82-83. PubMed ID: 29937379
    [No Abstract]   [Full Text] [Related]  

  • 6. PHACES syndrome: otolaryngic considerations in recognition and management.
    Rudnick EF; Chen EY; Manning SC; Perkins JA
    Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):281-8. PubMed ID: 19081148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of propranolol for treatment of hemangiomas in PHACE syndrome.
    Solomon T; Ninnis J; Deming D; Merritt TA; Hopper A
    J Perinatol; 2011 Nov; 31(11):739-41. PubMed ID: 22037156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propranolol therapy to treat problematic hemangiomas : a new standard therapy makes its debut].
    Löffler H; Kosel C; Cremer H; Kachel W
    Hautarzt; 2009 Dec; 60(12):1013-6. PubMed ID: 19859669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of infantile parotid hemangioma with propranolol].
    Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma.
    Denoyelle F; Leboulanger N; Enjolras O; Harris R; Roger G; Garabedian EN
    Int J Pediatr Otorhinolaryngol; 2009 Aug; 73(8):1168-72. PubMed ID: 19481268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infantile haemangioma and intracranial vascular malformation].
    Ommen LB; Helgestad J; Gammelgaard L
    Ugeskr Laeger; 2009 Sep; 171(38):2745-7. PubMed ID: 19758499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for isolated orbital infantile hemangioma.
    Fay A; Nguyen J; Jakobiec FA; Meyer-Junghaenel L; Waner M
    Arch Ophthalmol; 2010 Feb; 128(2):256-8. PubMed ID: 20142556
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma.
    Goto K; Ozeki M; Yasue S; Endo S; Fukao T
    Pediatr Int; 2020 Jun; 62(6):751-753. PubMed ID: 32490577
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of infantile hemangiomas with propranolol: clinical guidelines.
    Szychta P; Stewart K; Anderson W
    Plast Reconstr Surg; 2014 Apr; 133(4):852-862. PubMed ID: 24352207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late rebound of infantile hemangioma after cessation of oral propranolol.
    Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
    Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol.
    Pope E; Chakkittakandiyil A; Lara-Corrales I; Maki E; Weinstein M
    Br J Dermatol; 2013 Jan; 168(1):222-4. PubMed ID: 22762503
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative administration of propranolol reduced the surgical risks of PHACES syndrome in a 14-month-old girl.
    Rokugo Y; Ota C; Kimura M; Sasahara Y
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 31036736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma.
    Truong MT; Chang KW; Berk DR; Heerema-McKenney A; Bruckner AL
    J Pediatr; 2010 Feb; 156(2):335-8. PubMed ID: 20105647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm.
    Truong MT; Perkins JA; Messner AH; Chang KW
    Int J Pediatr Otorhinolaryngol; 2010 Sep; 74(9):1043-8. PubMed ID: 20674045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.